Gamechanger Series: Transformative Applications of Lipid Nanoparticles in mRNA Therapeutics
Deadline 2026-12-31Taylor & FrancisIndexed (Active)
Journal: International Journal of Nanomedicine
We are pleased to announce a new Article Collection in the International Journal of Nanomedicine , dedicated to the game-changing role of lipid nanoparticles (LNP) in the area of mRNA Therapeutics. Since their clinical introduction, mRNA-LNP therapeutics have revolutionized patient care, offering significant benefits in speed of development, therapeutic efficacy, and targeted delivery for eligible patients. Given th…
Advanced Nanomedicine Strategies for Targeted Drug Delivery and Precision Therapeutics
Deadline 2027-01-31Taylor & FrancisIndexed (Active)
Journal: International Journal of Nanomedicine
The field of nanomedicine has revolutionized the landscape of modern therapeutics by offering unprecedented control over the delivery of pharmaceutical agents. By utilizing engineered nanomaterials, researchers can now navigate complex biological environments to deliver drugs specifically to diseased tissues while minimizing systemic side effects. This Article Collection focuses on the latest breakthroughs in nanoca…
Artificial Intelligence Enabled Nanotechnology for Precision Theranostics
Deadline 2027-01-31Taylor & FrancisIndexed (Active)
Journal: International Journal of Nanomedicine
Artificial Intelligence (AI)-enabled nanotechnology is rapidly reshaping the design and application of advanced nanomaterials for biomedical diagnostics and drug delivery systems. The convergence of AI techniques—such as machine learning, deep learning, and predictive modeling—with functional nanomaterials (e.g., nanoparticles, nanocomposites, and stimuli-responsive systems) enables the rational design of highly eff…
From Bench to Bedside: Can Nanoparticles Transform Nuclear Medicine?
Deadline 2027-04-30Taylor & FrancisIndexed (Active)
Journal: International Journal of Nanomedicine
The integration of nanotechnology into nuclear medicine represents one of the most transformative frontiers in modern healthcare. Nanoparticles possess unique physicochemical properties, such as high surface-to-volume ratios, customizable surface chemistry, and tunable pharmacokinetics, that make them ideal vehicles for radiopharmaceuticals. By conjugating specific radionuclides to engineered nanomaterials, research…
Next-Generation Nanomedicine: From Tissue Engineering to Precision Cancer Treatment
Deadline 2027-04-30Taylor & FrancisIndexed (Active)
Journal: International Journal of Nanomedicine
The convergence of nanotechnology and materials science is ushering in a transformative era for healthcare, shifting the paradigm from conventional therapies to highly specific, molecular-level interventions. Next-Generation Nanomedicine lies at the forefront of this evolution, offering unprecedented control over biological interactions. This field focuses on the development of sophisticated nanomaterials and bio-in…
Targeted Nanomedicine for Solid Tumors: From Biomimetic Drug and Gene Delivery to Precision Oncology
Deadline 2027-04-30Taylor & FrancisIndexed (Active)
Journal: International Journal of Nanomedicine
Targeted nanomedicine is reshaping the therapeutic landscape of solid tumors by integrating rational nanosystem design with tumor biology, drug delivery science, and precision oncology. Lipid, polymeric, inorganic, hybrid, and biomimetic platforms can be engineered to improve the delivery of cytotoxic drugs, molecularly targeted agents, immunomodulators, and nucleic acid therapeutics. In parallel, biomimetic strateg…
Advanced Nanomedicine for Cancer Therapy and Autoimmune Immunotherapy
Deadline 2027-05-31Taylor & FrancisIndexed (Active)
Journal: International Journal of Nanomedicine
Immune-mediated diseases, including autoimmune disorders and cancer, represent major global health burdens arising from immune system dysfunction. Conventional therapies aim to suppress or activate immune responses, yet their lack of specificity often results in systemic toxicity, off-target effects, and limited therapeutic efficacy. Current immunotherapies often involve a trade-off between therapeutic efficacy and…
Reference integrity note: verify every citation against the original source before submission, including publication year, journal title, volume/issue, page range, DOI, and the target journal style.
DrAIStudio